{"type":"video","version":"1.0","html":"<iframe src=\"https://www.loom.com/embed/c9bb621788d7490e80b54151feee4824\" frameborder=\"0\" width=\"1920\" height=\"1440\" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe>","height":1440,"width":1920,"provider_name":"Loom","provider_url":"https://www.loom.com","thumbnail_height":1440,"thumbnail_width":1920,"thumbnail_url":"https://cdn.loom.com/sessions/thumbnails/c9bb621788d7490e80b54151feee4824-a4290459cdfa6b40.gif","duration":213.471,"title":"Innovative AI Discoveries in Alzheimer's and Beyond","description":"Hi, I'm excited to share my work on the Nicolas AI scientist, which is focused on novel drug discovery, particularly for Alzheimer's disease. Currently, the only FDA-approved drug for Alzheimer's is Donepezil, developed over 30 years ago, and my goal is to find innovative replacements. Nicolas operates using a unique architecture that allows it to autonomously generate and evaluate drug molecules without human intervention. I have conducted successful case studies in various domains, including oncology and anti-aging, and I encourage you to watch the demonstration of how Nicolas generates and validates these molecules. Your feedback on this process would be greatly appreciated!"}